These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3378209)

  • 1. Glutathione contents in human and rodent tumor cells in various phases of the cell cycle.
    Lee FY; Siemann DW; Allalunis-Turner MJ; Keng PC
    Cancer Res; 1988 Jul; 48(13):3661-5. PubMed ID: 3378209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione as a determinant of cellular response to doxorubicin.
    Lee FY; Vessey AR; Siemann DW
    NCI Monogr; 1988; (6):211-5. PubMed ID: 3352767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
    Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of glutathione levels in rodent and human tumor cells grown in vitro and in vivo.
    Allalunis-Turner MJ; Lee FY; Siemann DW
    Cancer Res; 1988 Jul; 48(13):3657-60. PubMed ID: 3378208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
    Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cell cycle-dependent cytotoxicity of adriamycin and 4-hydroperoxycyclophosphamide by novobiocin, an inhibitor of mammalian topoisomerase II.
    Lee FY; Flannery DJ; Siemann DW
    Cancer Res; 1992 Jul; 52(13):3515-20. PubMed ID: 1319822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP; Favier D; Parsons PG
    Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
    Messina JP; Lawrence DA
    J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N-methylformamide on the growth, cell cycle, and glutathione status of murine TLX5 lymphoma cells.
    Bill CA; Gescher A; Hickman JA
    Cancer Res; 1988 Jun; 48(12):3389-93. PubMed ID: 3370637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro.
    Barranco SC; Townsend CM; Weintraub B; Beasley EG; MacLean KK; Shaeffer J; Liu NH; Schellenberg K
    Cancer Res; 1990 Jun; 50(12):3614-8. PubMed ID: 2340510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of glutathione level in cultured human melanoma cells.
    Karg E; Brötell H; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(2):137-41. PubMed ID: 2564231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ
    Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle.
    Poot M; Teubert H; Rabinovitch PS; Kavanagh TJ
    J Cell Physiol; 1995 Jun; 163(3):555-60. PubMed ID: 7539813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F; Biscay P; Malaise EP; Guichard M
    Radiat Res; 1987 Apr; 110(1):149-54. PubMed ID: 2951766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.